HCL Technologies, Oracle Health Sciences collaborate to accelerate mHealth in clinical trials

06 Aug 2019 Evaluate

HCL Technologies (HCL) and Oracle Health Sciences have collaborated to help life sciences companies execute and scale the next generation of digital clinical trials to reduce the time and cost of drug development. The collaboration includes the availability of HCL's Faster Intelligent Trials (FIT) Solution using Oracle Health Sciences Mobile Health (mHealth) Connector Cloud Service (Oracle mHealth Cloud).

The company’s FIT solution can be leveraged for a number of use cases, including improving patient engagement, collecting patient reported outcomes, monitoring patient safety, improving medication adherence, or conducting e-visits during clinical trials to reduce patient and site burden. The solution can also be applied for drugs already launched commercially, such as for remote patient monitoring, gathering real world evidence, or as an accompanying application for digital therapies.

HCL Technologies is a leading global IT services company that helps global enterprises re- imagine and transform their businesses through digital technology transformation.

HCL Tech. Share Price

1360.40 -7.15 (-0.52%)
02-May-2024 16:01 View Price Chart
Peers
Company Name CMP
TCS 3863.75
Infosys 1414.85
HCL Tech. 1360.40
Wipro 457.25
Tech Mahindra 1266.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.